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Abstract
Background: Validated measures that can accurate describe young adults’ HPV vaccination attitudes and how these relate
to vaccination intention and receipt are needed for developing interventions to improve low HPV vaccination levels. The
Carolina HPV Immunization Attitudes Scale (CHIAS) is a validated measure of these outcomes that was originally designed
for parents.
Objective: To assess the performance of the CHIAS among young adult women using an exploratory factor analysis.
Methods: A convenience sample of 139 young adult women (age 18–26 years) were given the CHIAS measure at baseline.
Factor analysis was used to determine attitudinal factor groupings and the association of these factors with HPV vaccination
intention. A 6-month follow up assessment examined the stability of the CHIAS over time and the association of baseline
vaccine factors with vaccine receipt.
Results: Five factors loaded on to the CHIAS in young adults - ‘‘Barriers,’’ ‘‘Harms,’’ ‘‘Effectiveness,’’ ‘‘Risk Denial’’ and
‘‘Uncertainty,’’ - which was similar to the factor loadings of CHIAS for parents. ‘‘Harms’’ was the factor most consistently
associated with vaccination intention at all time points assessed. Only 5 women had received or made an appointment to
receive the vaccine at the 6-month follow-up.
Conclusions: In terms of categorizing HPV vaccination attitudes, the CHIAS appears to have similar performance among
young adults as in parents. However, additional studies are needed to assess the utility of the CHIAS for predicting HPV
vaccine receipt among the young adult population.
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Introduction
Vaccines against human papillomavirus (HPV) represent a
remarkable opportunity for the primary prevention of cervical
cancer and other HPV-related diseases. Despite these health
benefits, HPV vaccination among young adults in the U.S. is
significantly lower than national goals. [1] Compared to adoles-
cents, [2] young adult women have substantially lower HPV
vaccine utilization, with national estimates indicating that as of
2012, only 34.5% of women ages 19–28 years had received at least
one dose in the 3-dose HPV vaccine series. [3].
Interventions to improve HPV vaccine utilization among young
women have been hindered by limited understanding of the
factors that influence vaccine acceptability, intention, and
ultimately vaccine utilization among this population. [4] Though
there have been several studies on young women’s attitudes about
HPV vaccination, [5–7] a validated measure that can accurately
categorize attitudes about the vaccine and predict vaccination
intention and receipt is not yet available. However, such a measure
has been developed for parents making decisions about HPV
vaccination for their adolescents and is called the Carolina HPV
Immunization Attitudes Scale (CHIAS). [8–10].
The CHIAS, developed by McRee et al, was originally
evaluated among a regional sample of parents in North Carolina.
[8] Analysis of this 16-item scale resulted in the identification of 4
factors (Harms, Effectiveness, Barriers, Uncertainty) that catego-
rized parental attitudes about HPV vaccines. Subsequent longi-
tudinal analyses demonstrated the stability of these factors to
describe HPV vaccination attitudes over time. [9] Three the four
factors (all but Effectiveness) that were associated with parent HPV
vaccination intention also predicted actual HPV vaccine utiliza-
tion by these parents’ adolescents. When the CHIAS was
examined among a nationally-representative sample of parents, a
very similar factor structure resulted, suggesting that the CHIAS is
a robust measure of parental attitudes about the vaccine. [6]
Unfortunately, this national study did not assess the association
between the CHIAS factors and vaccine utilization.
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Having a similarly robust, standardized measure of HPV
vaccination attitudes for young women would be useful for
developing and examining interventions to improve HPV vaccine
uptake among this population. Therefore, the goal of this study
was to examine the factor structure of the CHIAS when applied to
a sample of young adult women. The specific objectives were: 1) to
compare the factor structure that results from young women’s use
of the CHIAS to that reported previously for parents, and 2) to
evaluate the association between the CHIAS factors and young
women’s HPV vaccination intention and utilization.
Materials and Methods
Study Design
We conducted a cross sectional survey of 139 college-aged
women that was implemented from October 11, 2011 to
November 1, 2012. This survey was part of a larger study aimed
at evaluating the longitudinal impact of different educational
materials on HPV vaccination intention and receipt (end result
was no difference in these outcomes by educational group), and on
hormonal stress responses to those materials (manuscript in
preparation). The focus of this manuscript is on responses to
CHIAS items specifically.
Ethics Statement
This study was approved by the Institutional Review Board at
the University of Michigan. Written informed consent was
received from all participants.
Participants
Participants were recruited via a Psychology participant pool
and flyers posted on campus and in the local town advertising a
study about HPV vaccines. Eligibility criteria for participation
included being a female aged 18–26 years and not yet having
received any doses in the HPV vaccine series. Upon arriving to the
study lab and providing informed consent, participants received a
paper version of the baseline survey to complete in a private
cubicle in the lab. Follow-up surveys were emailed to participants
and administered via Qualtrics with up to 2 prompts for non-
respondents.
CHIAS Items
We used all 16 items described in the original CHIAS [11] and
also included one additional item from a modified version of the
CHIAS that had been validated previously among a national
sample of parents (‘‘HPV vaccination is not really necessary because Pap
smears can be done to make sure cervical cancer doesn’t develop’’). [6] For
each item derived from previous versions of the CHIAS, wording
was changed to reflect a young adult, rather than parent,
perspective (i.e. ‘‘Other parents in my community are getting their daughters
vaccinated’’ becomes ‘‘My friends are getting the HPV vaccine’’). A side-
by-side comparison of the original CHIAS items and the modified
items used for this analysis is described in Table 1. All responses
were assessed using an 11-point Likert scale (with anchors at 0, 5, 7
and 10 of ‘‘strongly disagree,’’ ‘‘somewhat disagree,’’ ‘‘somewhat
agree’’ and ‘‘strongly agree’’; or anchored at ‘‘extremely ineffec-
tive, ‘‘somewhat ineffective,’’ ‘‘somewhat effective’’ and ‘‘extreme-
ly effective’’) and were coded such that higher values corresponded
to stronger agreement with the statement and less agreement with
or endorsement of HPV vaccination. Five items were reverse-
coded.
Outcome Variables
HPV vaccination intention and receipt were assessed as
outcome variables. HPV vaccination intention was measured with
two items that asked participants about the likelihood of getting
the vaccine ‘‘today if it was available for you,’’ or ‘‘within the next 6
months’’ using a previously-published 11-point vaccination inten-
tion scale. [12–14] This outcome was asked at baseline, and at a 6-
month follow-up survey. Vaccination ‘‘receipt’’ was determined by
self-report at the 6-month follow-up survey and was defined as a
positive response to at least one of two questions: ‘‘Since you were in
the lab for the first part of the study 6 months ago, have you received any doses
(shots/injections) of the HPV vaccine?’’ (yes/no), and ‘‘Have you made an
appointment to get the vaccine?’’ (yes/no).
Statistical Analysis
An exploratory factor analysis of the baseline CHIAS items was
conducted using principal components analysis with oblique
rotation method (as factors were assumed to be correlated).
Factors meeting the Kaiser criterion (Eigenvalues $1.0) were
retained. Non-weighted factor scores (consistent with previous
CHIAS assessments) [8,9,13] were created for each respondent by
calculating the mean of the responses to all items loading onto
each factor. Cronbach’s a coefficient was used to evaluate the
internal reliability of each factor grouping. We performed our
factor analysis forcing a four factor solution, in order to assess how
well the original CHIAS factor groupings applied to this
population, and also under an ‘‘unrestricted’’ factor strategy.
Linear and logistic multivariable regression models were used to
examine the association between the different factor groupings
with vaccination intention and uptake, respectively. Each model
included the 5 factors derived from the exploratory factor analysis,
but no other covariates were added given our relatively small
sample size (n = 139). For all analyses, p-values #0.05 were
considered statistically significant. All analyses were performed
using SPSS 20).
Results
Study Sample
Of the 139 participants who completed the baseline survey, 98
(70.5%) also completed the 6-month follow-up survey. As shown in
Table 2, at baseline 41% of respondents were in a current sexual
relationship, and nearly all had heard of HPV and knew a vaccine
was available. Only a small proportion of respondents indicated
they had ever experienced an HPV-related disease (2–5%).
Factor Structure among Young Women
When using a forced 4-factor solution, the exploratory factor
analysis had good consistency in factor groupings with the original
CHIAS for the ‘‘Barriers’’ and ‘‘Harms’’ factors. However, the
statements loading to the ‘‘Effectiveness’’ and ‘‘Uncertainty’’
factors were markedly different from the original CHIAS under
this solution strategy. When the analysis was repeated removing
the restriction to 4 factors, the exploratory factor analyses
demonstrated 5 factor groupings (Table 2), which included the
four original CHIAS factors plus an additional factor which we
labeled ‘‘Risk Denial’’. Three of the factors, ‘‘Barriers,’’ ‘‘Harms,’’
and ‘‘Effectiveness,’’ showed good internal reliability (Cronbach’s
alpha 0.74–0.91, Table 3). The internal reliability of the other two
factors, was considerably lower (0.43–0.49, Table 3).
CHIAS Performance in Young Adult Women
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Association of Baseline Factors with Vaccination Intent
Assessed at Baseline
As shown in Table 4, all the factors except Uncertainty were
associated with vaccination intention when assessed at baseline for
the outcome of willingness to receive the vaccine if it were
available ‘‘today.’’ Higher perceived difficulty in accessing the
vaccine (Barriers factor) was associated with increased vaccination
intention whereas increased concern about harms (Harms factor),
lower perceived effectiveness (Effectiveness factor) and stronger
risk denial attitudes (Risk Denial factor) were associated with lower
vaccination intention. Interestingly, when assessing vaccination
intention for the coming 6 months, the Barriers and Risk Denial
factors were no longer associated with this outcome (Table 4).
Table 1. Comparison of Original CHIAS items and Modifications Used for this Study.
Original CHIAS Modified CHIAS used in this Study
The HPV vaccine might cause short term problems, like fever or discomfort. I think the HPV vaccine might cause short term problems, like fever or discomfort.
The HPV vaccine is being pushed to make money for drug companies. The HPV vaccine is being pushed to make money for drug companies and/or doctors.
The HPV vaccine might cause lasting health problems. I think the HPV vaccine might cause health problems in the future.
If a teenage girl get this HPV vaccine, she may be more likely to have sex. I think that getting the HPV vaccine makes it more likely for someone to have sex.
I think the HPV vaccine is safe. I think the HPV vaccine is safe.
[Child’s name] is too young to get the HPV vaccine. I think I am too young to get a vaccine for a sexually transmitted infection like HPV.
How hard do you think it would be to find a provider or clinic where you
can afford the vaccine?
It would be hard to find a provider or clinic where I could afford the HPV vaccine.
How hard do you think it would be to find a provider or clinic that is
easy to get to?
It would be hard to find a provider or clinic that would be easy to get to for getting
vaccinated against HPV.
How hard do you thin k it would be find a provider or clinic that has the
vaccine available?
It would be hard to find a provider or clinic that has the HPV vaccine available.
I am concerned that the HPV vaccine costs more than I can pay. I am concerned that the HPV vaccine costs more than I can pay.
How hard do you think it would be to find a provider or clinic where you
don’t have to wait long to get an appointment?
It would be hard to find a provider or clinic where I don’t have to wait a long time to
get an appointment to be vaccinated.
How effective do you think the HPV vaccine is in preventing genital warts? How effective do you think the HPV vaccine is in preventing genital warts?
How effective do you think the HPV vaccine is in preventing cervical cancer? How effective do you think the HPV vaccine is in preventing cervical cancer?
I don’t have enough information about the HPV vaccine to decide whether
to give it to [child’s name].
I have enough information about the HPV vaccine to decide whether to get it.
The HPV vaccine is so new that I want to wait a while before deciding if
my daughter should get it.
The HPV vaccine is so new that I want to wait a while before deciding if I should get
it.
Other parents in my community are getting their daughters the
HPV vaccine.
My friends are getting the HPV vaccine.
– HPV vaccination is not really necessary because Pap smears can be done to make sure
cervical cancer doesn’t develop.
doi:10.1371/journal.pone.0100193.t001
Table 2. Sample Characteristics of College-Aged Females in Study at Baseline.
Variable Sample N=139
Mean age, yrs (range) 20 (19–25)
% Currently in sexual relationship* 41%
Lifetime number of sexual partners (range)* 1 (0–8)
Relationship status (%)
Single and not dating 55%
Dating more than one person 1%
In a relationship with one person only (dating, engaged, married) 44%
% Ever heard of HPV 94%
% Knew there was an HPV vaccine available 98%
% Ever diagnosed with genital warts 2%
% Ever diagnosed with an abnormal Pap smear 5%
% Never diagnosed with a sexually transmitted infection 99%
*Sexual partner and sexual relationship were defined as having any intimate genital contact.
doi:10.1371/journal.pone.0100193.t002
CHIAS Performance in Young Adult Women
PLOS ONE | www.plosone.org 3 June 2014 | Volume 9 | Issue 6 | e100193
Table 3. Factor Profiles of the CHIAS Assessed at Baseline and at 6-month Follow-up.
Factor Items Barriers Harms Effectiveness
Risk
Denial Uncertainty Eigenvalues
It would be hard to find a provider or clinic that would be
easy to get to for getting vaccinated against HPV.
0.924 20.004 20.034 0.077 0.150 4.111
It would be hard to find a provider or clinic where I could
afford the HPV vaccine.
0.913 0.050 20.058 0.068 0.156 3.697
It would be hard to find a provider or clinic that has the
HPV vaccine available.
0.890 20.072 0.037 0.161 0.218 1.426
I am concerned the HPV vaccine costs more than I can pay. 0.873 0.020 20.064 0.025 0.132 1.190
It would be hard find a provider or clinic where I don’t
have to wait a long time to get an appt. to be vaccinated.
0.801 20.067 20.001 0.039 0.121 1.050
I think the HPV vaccine may cause health problems
in the future.
20.072 0.897 0.251 0.298 0.061 0.893
I think the HPV vaccine is unsafe. 20.017 0.836 0.423 0.267 0.195 0.838
I think the HPV vaccine might cause short term problems
like fever or discomfort.
0.067 0.717 0.180 20.060 20.074 0.733
The HPV vaccine is so new that I want to wait a while
before deciding if I should get it.
20.141 0.694 0.068 0.500 0.039 0.649
I think the HPV vaccine is being pushed to make money
for drug companies and/or doctors.
0,033 0.559 0.289 0.339 0.150 0.533
How effective do you think the HPV vaccine is in
preventing genital warts? If you don’t know, make
your best guess.*
20.167 0.209 0.869 0.055 0.105 0.451
How effective do you think the HPV vaccine is in
preventing cervical cancer?*
0.033 0.402 0.843 0.265 0.033 0.431
I think that getting the HPV vaccine makes it more likely
for someone to have sex.
0.022 0.121 0.122 0.738 0.129 0.345
HPV vaccination is not really necessary because Pap
smears can be done to make sure cervical cancer doesn’t
develop.
0.124 0.200 0.046 0.659 0.070 0.267
I think I am too young to get a vaccine for a sexually
transmitted infection like HPV.
0.112 0.301 0.151 0.578 20.164 0.172
I have enough information about the HPV vaccine to
decide whether to get it.*
0.182 0.087 20.011 0.115 0.868 0.149
My friends are getting the HPV vaccine.* 0.237 0.099 0.455 20.045 0.639 0.065
Factor Mean (SD) 1.60 (1.85) 4.87 (2.04) 4.10 (1.36) 2.61 (1.78) 5.30 (2.32) –
Factor Cronbach Alpha 0.92 0.81 0.74 0.49 0.43 –
*Items were reverse-coded to maintain consistency, with higher values corresponding to less support for HPV vaccines.
Bolded items demonstrate factor groupings.
doi:10.1371/journal.pone.0100193.t003
Table 4. Relationship Between Factors and Baseline Intentions for HPV Vaccine***.
Baseline Vaccination Intention for ‘‘today’’* Baseline Vaccination Intention for the ‘‘next 6 months**
Baseline Factors Standardized Beta Coefficients p-value Standardized Beta Coefficients p-value
Access 0.33 0.002 0.12 0.29
Harms 20.53 ,0.001 20.31 0.007
Effectiveness 20.35 0.02 20.38 0.02
Risk Denial 20.27 0.02 20.24 0.06
Uncertainty 20.06 0.46 20.04 0.69
*Assessed at baseline by measuring response to the question ‘‘If the HPV vaccine was available for you today, how likely would you be to get vaccinated?’’.
**Assessed at baseline by measuring response to the question ‘‘How likely are you to get the HPV vaccine within the next 6 months?’’.
***Multivariable model that includes all factors listed.
Bolded values highlight statistically significant relationship.
doi:10.1371/journal.pone.0100193.t004
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Association of Baseline Factors with Vaccination Intent
Assessed at Follow-up
Comparing Tables 4 and 5, there were notable differences in
the relationship between the factors and vaccination intention
when participants were assessed at baseline versus at the 6-month
follow-up. In contrast to the baseline assessment (Table 4), only
Barriers and Harms were associated with vaccination intention for
‘‘today,’’ and only Harms was were associated with vaccination
intention for the coming 6 months when assessed at the follow-up
survey (Table 5).
Association of Baseline Factors with Vaccination Receipt
at Follow-Up
Only 5 out of 98 women (5.1%) completing the 6-month follow-
up assessment indicated that they had either received the HPV
vaccine or made an appointment to get it since the baseline
assessment. These low numbers precluded us from being able to
perform any meaningful statistical analyses on how well the factors
identified using CHIAS predicted vaccination uptake.
Discussion
Measures that reliably predict HPV vaccination intention across
populations and over time could help facilitate the development of
effective interventions to improve HPV vaccine uptake. The
original CHIAS [15] was tested among parents of adolescents and
found to be a useful tool to categorize HPV vaccination attitudes,
with each identified factor reliably predicting vaccination intention
over time, and three of the four factors longitudinally predicting
vaccination receipt. When we evaluated the factor loadings of the
CHIAS among young adult women, we found the overall factor
structure to be robust - there were significant similarities in the
items loading to the Barriers, Harms, Effectiveness and Uncer-
tainty factors between young women in our study and prior
analyses of CHIAS in parents. However, in our study a new factor
emerged from the CHIAS, which we termed Risk Denial. This
new factor contained correlates of two statements that loaded to
Harms in the original CHIAS (‘‘I think that getting the HPV
vaccine makes it more likely for someone to have sex’’ and ‘‘I think
I am too young to get a vaccine for a sexually transmitted
infection) in addition to the new item added for assessment in our
study (‘‘HPV vaccination is not necessary because Pap smears can
be done to make sure cervical cancer doesn’t develop’’). It was
notable that 2 of the 3 items loading to the Risk Denial factor
relate to low perceived risk of HPV infection or sequelae (vaccine
non necessary because of Pap tests; too young to get a vaccine
against an STI). Our results suggest that young women may have
subtle differences in attitudes about HPV vaccines from parents of
adolescents that could be important to consider for intervention to
improve vaccine uptake among this population. Furthermore, our
findings may indicate a heightened need to ‘‘convince’’ young
women about their individual risk for HPV infection and disease.
Moreover, the finding that items loading to the Harms construct
appear to be consistent and reliable across populations, combined
with the fact that in our study Harms is the most consistent
predictor of vaccination intention both immediately and longer-
term, suggests that interventions focusing on mitigating concerns
about the vaccine’s harms may be a particularly effective
educational strategy for increasing HPV vaccination among young
adults.
An interesting finding from our study was the association
between the Barriers factor and vaccination intention. When
assessed at baseline, young adults with higher perceived barriers to
accessing the vaccine had an increased vaccination intention if the
vaccine were available ‘‘today.’’ In contrast, at baseline there was
no association between Barriers and vaccination intention when
intentions for the ‘‘next 6 months’’ were assessed as the outcome,
or when vaccination intention was assessed for either time frame in
the follow-up survey. This finding could signify that the young
women in the study had a very literal interpretation of having ‘‘the
vaccine available for you today.’’ Participants may have believed
that they would have opportunity to get the vaccine in the study
lab after taking the baseline assessment (which was not the case). If
so, it is understandable that those with higher perceived barriers to
accessing the vaccine would have a higher vaccination intention
for a vaccine that might be immediately available, and that access
would be unrelated to a vaccine dose theoretically available 6
months in the future, or when reassessed by email where
‘‘vaccinating today’’ by the study team was obviously not a
realistic possibility. These findings suggest that coupling HPV
vaccination education with immediate access to the vaccine may
be an effective strategy to increase HPV utilization among young
adults.
In the original CHIAS study in parents, [8] Harms, Effective-
ness, Barriers and Uncertainty were all associated with vaccination
intention, and all but Effectiveness was associated with actual
vaccine receipt when vaccination status was assessed a year later.
[9] In our study there were only 5 women who reported either
getting the vaccine or making an appointment to get the vaccine
between the baseline and follow-up assessments, making it difficult
Table 5. Relationship Between Baseline Factors and 6-month Follow-up Intentions for HPV Vaccine¥***.
Follow-up Vaccination Intention for ‘‘today’’* Follow-up Vaccination Intention for the ‘‘next 6 months**
Baseline Factors Standardized Beta Coefficients p-value Standardized Beta Coefficients p-value
Access 0.18 0.025 0.11 0.18
Harms 20.42 ,0.001 20.35 ,0.001
Effectiveness 20.05 0.57 20.11 0.21
Risk Denial 20.11 0.17 20.12 0.15
Uncertainty 20.07 0.39 20.01 0.95
*Assessed at follow-up by measuring response to the question ‘‘If the HPV vaccine was available for you today, how likely would you be to get vaccinated?’’.
**Assessed at follow-up by measuring response to the question ‘‘How likely are you to get the HPV vaccine within the next 6 months?’’.
*** Multivariable model that includes all factors listed.
¥Follow-up survey occurred 6 months after baseline. N = 98.
Bolded values highlight statistically significant relationship.
doi:10.1371/journal.pone.0100193.t005
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to draw conclusions about the interrelationship between CHIAS
factors, vaccination intention and vaccine receipt in young adults –
an unfortunate limitation of our study. Other limitations that are
important to consider for this study are the relatively small sample
size that was drawn from a limited geographic area, which impacts
the generalizability of the results. In addition, participants involved
in the study were exposed to one of four different educational
materials immediately after their baseline assessment. While none
of the interventions appeared to have impacted vaccination
intention or receipt (manuscript in preparation) either when
assessed immediately following the intervention or at the 6-month
follow-up, it is possible that the variability of educational materials
could have had subtle influences on the CHIAS factor loadings
when assessed over time.
Conclusions
CHIAS items appear to group into very similar factors when
comparing parents making decisions about HPV vaccination for
their adolescents to young women making the HPV vaccination
decision for themselves, suggesting that the CHIAS is robust
measure for categorizing HPV vaccination attitudes. However, the
association of these factors with vaccination intention appears to
differ between parents and young adults. Harms was the only
factor that performed similarly between these two populations and
also consistently predicted vaccination intention over a variety of
time frames. This suggests that educational strategies focusing on
mitigating perceived harms from the vaccine may have the widest
influence and appeal across populations of different ages.
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